ORIGINAL ARTICLES

Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis

S Mohammed, S Goodacre

Medical Care Research Unit, University of Sheffield, Sheffield, UK

Correspondence to:
Professor S Goodacre, Medical Care Research Unit, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK; s.goodacre{at}sheffield.ac.uk

Objectives: To estimate the effect of intravenous and nebulised magnesium sulphate upon hospital admissions and pulmonary function in adults and children with acute asthma.

Methods: We undertook a systematic review and meta-analysis of randomised and quasi-randomised trials of intravenous or nebulised magnesium sulphate in acute asthma. Trials were identified by searches of the electronic literature, relevant journal websites and conference proceedings, and contact with authors and experts. Data were pooled using random effects meta-analysis of the relative risk (RR) of hospital admission and the standardised mean difference (SMD) in pulmonary function.

Results: 24 studies (15 intravenous, 9 nebulised) incorporating 1669 patients were included. Intravenous treatment was associated in adults with weak evidence of an effect upon respiratory function (SMD 0.25, 95% confidence interval (CI) –0.01 to 0.51; p = 0.05), but no significant effect upon hospital admission (RR 0.87, 95% CI 0.70 to 1.08; p = 0.22), and in children with a significant effect upon respiratory function (SMD 1.94, 95% CI 0.80 to 3.08; p<0.001) and hospital admission (RR 0.70, 95% CI 0.54 to 0.90; p = 0.005). Nebulised treatment was associated in adults with weak evidence of an effect upon respiratory function (SMD 0.17, 95% CI –0.02 to 0.36; p = 0.09), and hospital admission (RR 0.68, 95% CI 0.46 to 1.02; p = 0.06), and in children with no significant effect upon respiratory function (SMD –0.26, 95% CI –1.49 to 0.98; p = 0.69) or hospital admission (RR 2.0, 95% CI 0.19 to 20.93; p = 0.56).

Conclusion: Intravenous magnesium sulphate appears to be an effective treatment in children. Further trials are needed of intravenous and nebulised magnesium sulphate in adults and nebulised magnesium sulphate in children.

Abbreviations: BTS, British Thoracic Society; CI, confidence interval; RR, relative risk; SIGN, Scottish Intercollegiate Guidelines Network; SMD, standardised mean difference

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Primary Survey

Steve Goodacre
Emerg. Med. J. 2007 24: 807. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Jones, L A, Goodacre, S (2009). Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments. Emerg. Med. J. 26: 783-785 [Abstract] [Full Text]